Cardiopulmonary Interactions in Heart Failure and Chronic Lung Disease

Globally, cardiovascular diseases, which are directly related to cardiopulmonary interactions, affect over half a billion people and cause 20.5 million deaths in 2021. Cardiopulmonary interactions refer to the complex interactions between the heart and lungs, particularly in diseases where dysfunction in one organ significantly impacts the other. This research aims to discover treatments and prevention methods for Cardiopulmonary Interactions in Heart Failure and Chronic Lung Disease. The aim is to help find early detections of these diseases and educate the public on how to prevent these diseases. A systematic review analyzed 22 peer-reviewed studies out of 45 from 2010 to 2025, examining conditions like heart failure and chronic obstructive pulmonary disease (COPD) based on relevance, methodological rigor, and recency. The data found in the study shows that Positive Pressure Ventilation devices like the CPAP (Continuous Positive Airway Pressure), can help and treat different diseases in the cardiopulmonary system. From the review it was found that regular exercise can significantly reduce the risk of heart failure and improve outcomes for individuals with the condition, with some research indicating a 20-25% reduction in major cardiac mortality. This study captures how the cardiovascular system works with the pulmonary system in treatments and prevention of diseases like COPD and heart failure, such as CPAP and Positive Pressure Ventilation Systems. Educating the public on how to prevent and treat COPD and Heart failure from cardiopulmonary interactions is extremely important considering over half a billion people are affected by diseases relating to cardiopulmonary interactions.